Nikolaos Grigoriadis

Axonal damage in multiple sclerosis: a complex issue in a complex disease

Ioannis Milonas, T. Ben-Hur, D. Karussis, 2004, Clinical Neurology and Neurosurgery.

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

Simon Hametner, Hans Lassmann, H. Lassmann, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Ludwig Kappos, Jan Hillert, Gilles Edan, 2007, The Lancet Neurology.

Neuroprotection in multiple sclerosis

D. Karussis, N. Grigoriadis, O. Abramsky, 2006, Clinical Neurology and Neurosurgery.

EEG Window Length Evaluation for the Detection of Alzheimer’s Disease over Different Brain Regions

Nikolaos Giannakeas, Pantelis Angelidis, Loukas G Astrakas, 2019, Brain sciences.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Helicobacter pylori might contribute to nonalcoholic fatty liver disease–related cardiovascular events by releasing prothrombotic and proinflammatory factors

Jannis Kountouras, J. Kountouras, S. Polyzos, 2014, Hepatology.

D‐cycloserine improves functional recovery and reinstates long‐term potentiation (LTP) in a mouse model of closed head injury

Anat Biegon, Esther Shohami, A. Biegon, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.